35
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID‐19

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Context

          No studies evaluated the prospective association between hyperglycemia assessed by laboratory measurements and the risk of mortality among patients with coronavirus disease 2019 (COVID‐19).

          OBJECTIVE

          We aimed to evaluate the association between different degrees of hyperglycemia and the risk of all‐cause mortality among hospitalized patients with COVID‐19.

          DESIGN

          A retrospective study.

          SETTING

          Union Hospital in Wuhan, China.

          PARTICIPANTS

          453 patients were admitted to the hospital with laboratory‐confirmed SARS‐Cov‐2 infection from January 22, 2020 to March 17, 2020.

          MAIN OUTCOMES AND MEASURES

          Patients were classified into four categories: normal glucose, hyperglycemia (fasting glucose 5.6–6.9 mmol/L and/or HbA1c 5.7–6.4%), newly diagnosed diabetes (fasting glucose ≥7 mmol/L and/or HbA1c ≥6.5%), and known diabetes. The major outcomes included in‐hospital mortality, intensive care unit (ICU) admission, and invasive mechanical ventilation (IMV).

          RESULTS

          Patients with newly diagnosed diabetes had the highest percentage to be admitted to the ICU (11.7%) and require IMV (11.7%), followed by patients with known diabetes (4.1%; 9.2%) and patients with hyperglycemia (6.2%; 4.7%), compared with patients with normal glucose (1.5%; 2.3%), respectively. The multivariable‐adjusted hazard ratios of mortality among COVID‐19 patients with normal glucose, hyperglycemia, newly diagnosed diabetes, and known diabetes were 1.00, 3.29 (95% confidence interval [CI] 0.65–16.6), 9.42 (95% CI 2.18–40.7), and 4.63 (95% CI 1.02–21.0), respectively.

          CONCLUSION

          We firstly showed that COVID‐19 patients with newly diagnosed diabetes had the highest risk of all‐cause mortality compared with COVID‐19 patients with known diabetes, hyperglycemia and normal glucose. Patients with COVID‐19 need to be under surveillance for blood glucose screening.

          This article is protected by copyright. All rights reserved.

          Related collections

          Author and article information

          Contributors
          cheria_chen@126.com
          zhengjuan25@163.com
          Journal
          Diabetes Obes Metab
          Diabetes Obes Metab
          10.1111/(ISSN)1463-1326
          DOM
          Diabetes, Obesity & Metabolism
          Blackwell Publishing Ltd (Oxford, UK )
          1462-8902
          1463-1326
          29 May 2020
          : 10.1111/dom.14099
          Affiliations
          [ 1 ] Department of Endocrinology, Union Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan China
          [ 2 ] Hubei provincial Clinical Research Center for Diabetes and Metabolic Disorders Wuhan China
          Author notes
          [*] [* ] Correspondence

          Dr. Juan Zheng, Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, Email: zhengjuan25@ 123456163.com and Dr. Lulu Chen, Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China,

          Email: cheria_chen@ 123456126.com

          [†]

          These authors contributed equally to this work and are considered as co‐first authors.

          Author information
          https://orcid.org/0000-0003-1140-5647
          https://orcid.org/0000-0001-7950-5586
          https://orcid.org/0000-0001-9621-9231
          Article
          DOM14099 DOM-20-0549-OP.R1
          10.1111/dom.14099
          7283710
          32469464
          72b1b5a7-0a79-4abf-acbc-f495b041dcce
          This article is protected by copyright. All rights reserved.

          This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.

          History
          : 12 May 2020
          : 17 May 2020
          : 17 May 2020
          Page count
          Figures: 2, Tables: 4, Pages: 1, Words: 6800
          Categories
          Original Article
          Original Articles
          Custom metadata
          2.0
          accepted-manuscript
          Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.4 mode:remove_FC converted:10.06.2020

          Endocrinology & Diabetes
          Endocrinology & Diabetes

          Comments

          Comment on this article